해외 임상시험 정보 데이터(GlobalData) 보고서 업데이트 안내 6.20. (목)

구분	보고서(영문)
제약/바이오/ 임상시험 (3건)	Tapinarof May Mark Dermavant’s First Atopic Dermatitis Approval
	Moderna Announces Positive Phase III Data for COVID-19/Influenza mRNA Vaccine
	Beacon Therapeutics Treats First Patient with AGTC-501 in Pivotal Trial, VISTA
질환별 (7건)	Niemann-Pick Disease Type C: Rare Disease Patients Awaiting Disease-Modifying Drugs
	Niemann-Pick Type C: Opportunity Assessment and Forecast - Update
	Chronic Kidney Disease: Epidemiology Forecast to 2033
	WHO Publishes New Mpox Prevention and Management Framework
	Vitiligo: Competitive Landscape
	Revolutionizing Cystic Fibrosis Treatment: Advances, Challenges, and Future Prospects
	Spinal Cord Injury: Competitive Landscape
컨퍼런스/심포지엄/ 학회/기타 (11건)	EHA 2024: SEQUOIA Trial for Brukinsa/Venclexta in CLL/SLL Holds Promise but Lacks Control Arm
	EHA 2024: Roche’s Columvi Competes in BiTE Battle with Positive Results in DLBCL
	EHA 2024: Novartis’s Scemblix Takes on All TKIs in Head-to-Head CML Trial
	EHA 2024: AstraZeneca’s Calquence plus chemoimmunotherapy offer new SOC treatment for MCL
	EHA2024: Odronextamab Shows Promise in ELM-2 Study for Follicular Lymphoma
	EHA 2024 Highlights: Continued Dominance of Monoclonal Antibodies in Multiple Myeloma Treatment
	ASCO 2024: Blood Cancer Highlights
	Exposure to Particulate Matter 2.5 Increases Risk of “Diabesity”
	Ukraine: A Market Access Review Over Two Years of War
	American Society of Clinical Oncology (ASCO) 2024 Highlights
	Blood Matching Tests by the NHS May Improve Blood Transfusion Outcomes